{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:13:02Z","timestamp":1793329982624,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10555-020-09910-w","type":"journal-article","created":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T00:03:07Z","timestamp":1593302587000},"page":"825-835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"Yang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"key":"9910_CR1","first-page":"363","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019). Cancer treatment and survivorship statistics, 2019. CA: a cancer journal for clinicians, 69, 363\u2013385.","journal-title":"CA: a cancer journal for clinicians"},{"key":"9910_CR2","doi-asserted-by":"crossref","unstructured":"W.O. Rebecca, M.A. Richard, Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus, The Cochrane database of systematic reviews, (2003) Cd002092.","DOI":"10.1002\/14651858.CD002092"},{"key":"9910_CR3","doi-asserted-by":"crossref","unstructured":"E. Wakeam, S.A. Acuna, N.B. Leighl, M.E. Giuliani, S.R.G. Finlayson, T.K. Varghese, G.E. Darling, Surgery versus chemotherapy and radiotherapy for early and locally advanced small cell lung cancer: a propensity-matched analysis of survival, Lung cancer (Amsterdam, Netherlands), 109 (2017) 78-88.","DOI":"10.1016\/j.lungcan.2017.04.021"},{"key":"9910_CR4","doi-asserted-by":"crossref","unstructured":"M.L. Ashdown, A.P. Robinson, S.L. Yatomi-Clarke, M.L. Ashdown, A. Allison, D. Abbott, S.N. Markovic, B.J. Coventry, Chemotherapy for late-stage cancer patients: meta-analysis of complete response rates, F1000Research, 4 (2015) 232.","DOI":"10.12688\/f1000research.6760.1"},{"key":"9910_CR5","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1021\/cr900208x","volume":"109","author":"DS Shewach","year":"2009","unstructured":"Shewach, D. S., & Kuchta, R. D. (2009). Introduction to cancer chemotherapeutics. Chemical reviews, 109, 2859\u20132861.","journal-title":"Chemical reviews"},{"key":"9910_CR6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","volume":"9","author":"L Falzone","year":"2018","unstructured":"Falzone, L., Salomone, S., & Libra, M. (2018). Evolution of cancer pharmacological treatments at the turn of the third millennium. Frontiers in pharmacology, 9, 1300.","journal-title":"Frontiers in pharmacology"},{"key":"9910_CR7","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014). Drug resistance in cancer: an overview. Cancers, 6, 1769\u20131792.","journal-title":"Cancers"},{"issue":"Suppl 1","key":"9910_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1634\/theoncologist.2011-S1-30","volume":"16","author":"SM Swain","year":"2011","unstructured":"Swain, S. M. (2011). Chemotherapy: updates and new perspectives. The oncologist, 16(Suppl 1), 30\u201339.","journal-title":"The oncologist"},{"key":"9910_CR9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/IGC.0000000000001023","volume":"27","author":"N Colombo","year":"2017","unstructured":"Colombo, N., Lorusso, D., & Scollo, P. (2017). Impact of recurrence of ovarian cancer on quality of life and outlook for the future. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 27, 1134\u20131140.","journal-title":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society"},{"key":"9910_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017). The different mechanisms of cancer drug resistance: a brief review. Advanced pharmaceutical bulletin, 7, 339\u2013348.","journal-title":"Advanced pharmaceutical bulletin"},{"issue":"Suppl 1","key":"9910_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000086183","volume":"14","author":"YA Luqmani","year":"2005","unstructured":"Luqmani, Y. A. (2005). Mechanisms of drug resistance in cancer chemotherapy. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 14(Suppl 1), 35\u201348.","journal-title":"Medical principles and practice : international journal of the Kuwait University, Health Science Centre"},{"key":"9910_CR12","volume-title":"Targeting cancer stem cells to overcome chemoresistance, International journal of molecular sciences, 19","author":"T Nunes","year":"2018","unstructured":"T. Nunes, D. Hamdan, C. Leboeuf, M. El Bouchtaoui, G. Gapihan, T.T. Nguyen, S. Meles, E. Angeli, P. Ratajczak, H. Lu, M. Di Benedetto, G. Bousquet, A. Janin, Targeting cancer stem cells to overcome chemoresistance, International journal of molecular sciences, 19 (2018)."},{"key":"9910_CR13","volume":"4","author":"X Sui","year":"2013","unstructured":"Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., Wang, X., He, C., & Pan, H. (2013). Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell death & disease, 4, e838.","journal-title":"Cell death & disease"},{"key":"9910_CR14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/cas.13342","volume":"108","author":"Y Kondo","year":"2017","unstructured":"Kondo, Y., Shinjo, K., & Katsushima, K. (2017). Long non-coding RNAs as an epigenetic regulator in human cancers. Cancer science, 108, 1927\u20131933.","journal-title":"Cancer science"},{"key":"9910_CR15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt, A. M., & Chang, H. Y. (2016). Long Noncoding RNAs in Cancer Pathways. Cancer cell, 29, 452\u2013463.","journal-title":"Cancer cell"},{"key":"9910_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature10398","volume":"477","author":"M Guttman","year":"2011","unstructured":"Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., Young, G., Lucas, A. B., Ach, R., Bruhn, L., Yang, X., Amit, I., Meissner, A., Regev, A., Rinn, J. L., Root, D. E., & Lander, E. S. (2011). lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature, 477, 295\u2013300.","journal-title":"Nature"},{"key":"9910_CR17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","volume":"19","author":"K Liu","year":"2020","unstructured":"Liu, K., Gao, L., Ma, X., Huang, J. J., Chen, J., Zeng, L., Ashby Jr., C. R., Zou, C., & Chen, Z. S. (2020). Long non-coding RNAs regulate drug resistance in cancer. Molecular cancer, 19, 54.","journal-title":"Molecular cancer"},{"key":"9910_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.gpb.2016.06.001","volume":"14","author":"J Wang","year":"2016","unstructured":"Wang, J., & Lindahl, T. (2016). Maintenance of genome stability. Genomics, proteomics & bioinformatics, 14, 119\u2013121.","journal-title":"Genomics, proteomics & bioinformatics"},{"key":"9910_CR19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cell.2017.01.002","volume":"168","author":"A Tubbs","year":"2017","unstructured":"Tubbs, A., & Nussenzweig, A. (2017). Endogenous DNA damage as a source of genomic instability in cancer. Cell, 168, 644\u2013656.","journal-title":"Cell"},{"key":"9910_CR20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/0008-5472.CAN-16-1151","volume":"77","author":"ZD Nagel","year":"2017","unstructured":"Nagel, Z. D., Kitange, G. J., Gupta, S. K., Joughin, B. A., Chaim, I. A., Mazzucato, P., Lauffenburger, D. A., Sarkaria, J. N., & Samson, L. D. (2017). DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme. Cancer research, 77, 198\u2013206.","journal-title":"Cancer research"},{"key":"9910_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2041-9414-3-9","volume":"3","author":"I Brandsma","year":"2012","unstructured":"Brandsma, I., & Gent, D. C. (2012). Pathway choice in DNA double strand break repair: observations of a balancing act. Genome integrity, 3, 9.","journal-title":"Genome integrity"},{"key":"9910_CR22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cas.12366","volume":"105","author":"N Hosoya","year":"2014","unstructured":"Hosoya, N., & Miyagawa, K. (2014). Targeting DNA damage response in cancer therapy. Cancer science, 105, 370\u2013388.","journal-title":"Cancer science"},{"key":"9910_CR23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nsmb.3211","volume":"23","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., He, Q., Hu, Z., Feng, Y., Fan, L., Tang, Z., Yuan, J., Shan, W., Li, C., Hu, X., Tanyi, J. L., Fan, Y., Huang, Q., Montone, K., Dang, C. V., & Zhang, L. (2016). Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Nature structural & molecular biology, 23, 522\u2013530.","journal-title":"Nature structural & molecular biology"},{"key":"9910_CR24","doi-asserted-by":"crossref","unstructured":"X. Wang, H. Liu, L. Shi, X. Yu, Y. Gu, X. Sun, LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation, Cell cycle (Georgetown, Tex.), 17 (2018) 439-447.","DOI":"10.1080\/15384101.2018.1442625"},{"key":"9910_CR25","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41467-019-10025-2","volume":"10","author":"P Wu","year":"2019","unstructured":"Wu, P., Cai, J., Chen, Q., Han, B., Meng, X., Li, Y., Li, Z., Wang, R., Lin, L., Duan, C., Kang, C., & Jiang, C. (2019). Lnc-TALC promotes O(6)-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p. Nature communications, 10, 2045.","journal-title":"Nature communications"},{"key":"9910_CR26","volume-title":"Melatonin sensitizes hepatocellular carcinoma cells to chemotherapy through long non-coding RNA RAD51-AS1-mediated suppression of DNA repair, Cancers, 10","author":"CC Chen","year":"2018","unstructured":"C.C. Chen, C.Y. Chen, S.H. Wang, C.T. Yeh, S.C. Su, S.H. Ueng, W.Y. Chuang, C. Hsueh, T.H. Wang, Melatonin sensitizes hepatocellular carcinoma cells to chemotherapy through long non-coding RNA RAD51-AS1-mediated suppression of DNA repair, Cancers, 10 (2018)."},{"key":"9910_CR27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.15252\/embr.201540437","volume":"16","author":"V Sharma","year":"2015","unstructured":"Sharma, V., Khurana, S., Kubben, N., Abdelmohsen, K., Oberdoerffer, P., Gorospe, M., & Misteli, T. (2015). A BRCA1-interacting lncRNA regulates homologous recombination. EMBO reports, 16, 1520\u20131534.","journal-title":"EMBO reports"},{"key":"9910_CR28","volume":"8","author":"Z Liu","year":"2013","unstructured":"Liu, Z., Sun, M., Lu, K., Liu, J., Zhang, M., Wu, W., De, W., Wang, Z., & Wang, R. (2013). The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1\/CIP1) expression. PloS one, 8, e77293.","journal-title":"PloS one"},{"key":"9910_CR29","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41419-018-1148-y","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang, H., Fang, L., Jiang, J., Kuang, Y., Wang, B., Shang, X., Han, P., Li, Y., Liu, M., Zhang, Z., & Li, P. (2018). The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. Cell death & disease, 9, 1103.","journal-title":"Cell death & disease"},{"key":"9910_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/OTT.S116178","volume":"10","author":"H Gao","year":"2017","unstructured":"Gao, H., Song, X., Kang, T., Yan, B., Feng, L., Gao, L., Ai, L., Liu, X., Yu, J., & Li, H. (2017). Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer. OncoTargets and therapy, 10, 205\u2013216.","journal-title":"OncoTargets and therapy"},{"key":"9910_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.coph.2006.01.009","volume":"6","author":"S Modok","year":"2006","unstructured":"Modok, S., Mellor, H. R., & Callaghan, R. (2006). Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Current opinion in pharmacology, 6, 350\u2013354.","journal-title":"Current opinion in pharmacology"},{"key":"9910_CR32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","volume":"9","author":"FJ Sharom","year":"2008","unstructured":"Sharom, F. J. (2008). ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics, 9, 105\u2013127.","journal-title":"Pharmacogenomics"},{"key":"9910_CR33","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/en.2019-00241","volume":"160","author":"E Abbasifarid","year":"2019","unstructured":"Abbasifarid, E., Sajjadi-Jazi, S. M., Beheshtian, M., Samimi, H., Larijani, B., & Haghpanah, V. (2019). The role of ATP-binding cassette transporters in the chemoresistance of anaplastic thyroid cancer: a systematic review. Endocrinology, 160, 2015\u20132023.","journal-title":"Endocrinology"},{"key":"9910_CR34","first-page":"111","volume":"161","author":"T Schondorf","year":"2003","unstructured":"Schondorf, T., Neumann, R., Benz, C., Becker, M., Riffelmann, M., Gohring, U. J., Sartorius, J., von Konig, C. H., Breidenbach, M., Valter, M. M., Hoopmann, M., Di Nicolantonio, F., & Kurbacher, C. M. (2003). Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 161, 111\u2013116.","journal-title":"Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer"},{"key":"9910_CR35","doi-asserted-by":"crossref","unstructured":"E.L. Christie, S. Pattnaik, J. Beach, A. Copeland, N. Rashoo, S. Fereday, J. Hendley, K. Alsop, S.L. Brady, G. Lamb, A. Pandey, A. deFazio, H. Thorne, A. Bild, D.D.L. Bowtell, Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer, Nature communications, 10 (2019) 1295.","DOI":"10.1038\/s41467-019-09312-9"},{"key":"9910_CR36","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.2147\/OTT.S172379","volume":"11","author":"H Gao","year":"2018","unstructured":"Gao, H., Hao, G., Sun, Y., Li, L., & Wang, Y. (2018). Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process. OncoTargets and therapy, 11, 8001\u20138012.","journal-title":"OncoTargets and therapy"},{"key":"9910_CR37","doi-asserted-by":"crossref","first-page":"91990","DOI":"10.18632\/oncotarget.21121","volume":"8","author":"QN Zhu","year":"2017","unstructured":"Zhu, Q. N., Wang, G., Guo, Y., Peng, Y., Zhang, R., Deng, J. L., Li, Z. X., & Zhu, Y. S. (2017). LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway. Oncotarget, 8, 91990\u201392003.","journal-title":"Oncotarget"},{"key":"9910_CR38","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1038\/sj.onc.1210266","volume":"26","author":"WP Tsang","year":"2007","unstructured":"Tsang, W. P., & Kwok, T. T. (2007). Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene, 26, 4877\u20134881.","journal-title":"Oncogene"},{"key":"9910_CR39","first-page":"3501","volume":"9","author":"P Jiang","year":"2016","unstructured":"Jiang, P., Wang, P., Sun, X., Yuan, Z., Zhan, R., Ma, X., & Li, W. (2016). Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. OncoTargets and therapy, 9, 3501\u20133509.","journal-title":"OncoTargets and therapy"},{"key":"9910_CR40","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.12659\/MSM.910932","volume":"24","author":"C Shi","year":"2018","unstructured":"Shi, C., & Wang, M. (2018). LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134\/ABCC1. Medical science monitor : international medical journal of experimental and clinical research, 24, 8831\u20138839.","journal-title":"Medical science monitor : international medical journal of experimental and clinical research"},{"key":"9910_CR41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2018.05.104","volume":"501","author":"J Wang","year":"2018","unstructured":"Wang, J., Ye, C., Liu, J., & Hu, Y. (2018). UCA1 confers paclitaxel resistance to ovarian cancer through miR-129\/ABCB1 axis. Biochemical and biophysical research communications, 501, 1034\u20131040.","journal-title":"Biochemical and biophysical research communications"},{"key":"9910_CR42","volume-title":"Non-coding RNA in drug resistance of hepatocellular carcinoma, Bioscience reports, 38","author":"B Ding","year":"2018","unstructured":"B. Ding, W. Lou, L. Xu, W. Fan, Non-coding RNA in drug resistance of hepatocellular carcinoma, Bioscience reports, 38 (2018)."},{"key":"9910_CR43","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1111\/jcmm.13605","volume":"22","author":"H Huang","year":"2018","unstructured":"Huang, H., Chen, J., Ding, C. M., Jin, X., Jia, Z. M., & Peng, J. (2018). LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363. Journal of cellular and molecular medicine, 22, 3238\u20133245.","journal-title":"Journal of cellular and molecular medicine"},{"key":"9910_CR44","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1158\/1541-7786.MCR-13-0636","volume":"12","author":"K Takahashi","year":"2014","unstructured":"Takahashi, K., Yan, I. K., Wood, J., Haga, H., & Patel, T. (2014). Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Molecular cancer research : MCR, 12, 1377\u20131387.","journal-title":"Molecular cancer research : MCR"},{"key":"9910_CR45","doi-asserted-by":"crossref","unstructured":"Z. Fang, W. Chen, Z. Yuan, X. Liu, H. Jiang, LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 101 (2018) 536-542.","DOI":"10.1016\/j.biopha.2018.02.130"},{"key":"9910_CR46","doi-asserted-by":"crossref","unstructured":"X. Wu, Y. Zheng, B. Han, X. Dong, Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 99 (2018) 832-838.","DOI":"10.1016\/j.biopha.2018.01.130"},{"key":"9910_CR47","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1101\/gad.914401","volume":"15","author":"RT Abraham","year":"2001","unstructured":"Abraham, R. T. (2001). Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes & development, 15, 2177\u20132196.","journal-title":"Genes & development"},{"key":"9910_CR48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J Bartek","year":"2003","unstructured":"Bartek, J., & Lukas, J. (2003). Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer cell, 3, 421\u2013429.","journal-title":"Cancer cell"},{"key":"9910_CR49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","volume":"8","author":"T Helleday","year":"2008","unstructured":"Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008). DNA repair pathways as targets for cancer therapy. Nature reviews. Cancer, 8, 193\u2013204.","journal-title":"Nature reviews. Cancer"},{"key":"9910_CR50","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm.4135","volume":"22","author":"C Adriaens","year":"2016","unstructured":"Adriaens, C., Standaert, L., Barra, J., Latil, M., Verfaillie, A., Kalev, P., Boeckx, B., Wijnhoven, P. W., Radaelli, E., Vermi, W., Leucci, E., Lapouge, G., Beck, B., van den Oord, J., Nakagawa, S., Hirose, T., Sablina, A. A., Lambrechts, D., Aerts, S., Blanpain, C., & Marine, J. C. (2016). p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nature medicine, 22, 861\u2013868.","journal-title":"Nature medicine"},{"key":"9910_CR51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41419-019-1513-5","volume":"10","author":"VY Shin","year":"2019","unstructured":"Shin, V. Y., Chen, J., Cheuk, I. W., Siu, M. T., Ho, C. W., Wang, X., Jin, H., & Kwong, A. (2019). Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Cell death & disease, 10, 270.","journal-title":"Cell death & disease"},{"key":"9910_CR52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/0008-5472.CAN-17-0815","volume":"78","author":"Y Lu","year":"2018","unstructured":"Lu, Y., Hu, Z., Mangala, L. S., Stine, Z. E., Hu, X., Jiang, D., Xiang, Y., Zhang, Y., Pradeep, S., Rodriguez-Aguayo, C., Lopez-Berestein, G., DeMarzo, A. M., Sood, A. K., Zhang, L., & Dang, C. V. (2018). MYC Targeted long noncoding RNA DANCR promotes cancer in part by reducing p21 Levels. Cancer research, 78, 64\u201374.","journal-title":"Cancer research"},{"key":"9910_CR53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-020-1137-5","volume":"19","author":"C Lu","year":"2020","unstructured":"Lu, C., Wei, Y., Wang, X., Zhang, Z., Yin, J., Li, W., Chen, L., Lyu, X., Shi, Z., Yan, W., & You, Y. (2020). DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Molecular cancer, 19, 28.","journal-title":"Molecular cancer"},{"key":"9910_CR54","first-page":"4220","volume":"23","author":"J Shang","year":"2019","unstructured":"Shang, J., Xu, Y. D., Zhang, Y. Y., & Li, M. (2019). Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1. European review for medical and pharmacological sciences, 23, 4220\u20134225.","journal-title":"European review for medical and pharmacological sciences"},{"key":"9910_CR55","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1002\/jcb.27851","volume":"120","author":"H Jiang","year":"2019","unstructured":"Jiang, H., Xiong, W., Chen, L., Lv, Z., Yang, C., & Li, Y. (2019). Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt\/beta-catenin pathway in prostate cancer. Journal of cellular biochemistry, 120, 8965\u20138974.","journal-title":"Journal of cellular biochemistry"},{"key":"9910_CR56","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ijc.32185","volume":"145","author":"W Sun","year":"2019","unstructured":"Sun, W., Xu, X., Jiang, Y., Jin, X., Zhou, P., Liu, Y., Guo, Y., Ma, D., Zuo, W., Huang, S., He, X., & Shao, Z. (2019). Transcriptome analysis of luminal breast cancer reveals a role for LOL in tumor progression and tamoxifen resistance. International journal of cancer, 145, 842\u2013856.","journal-title":"International journal of cancer"},{"key":"9910_CR57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12935-019-0934-7","volume":"19","author":"W Zuo","year":"2019","unstructured":"Zuo, W., Zhang, W., Xu, F., Zhou, J., & Bai, W. (2019). Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1. Cancer cell international, 19, 240.","journal-title":"Cancer cell international"},{"key":"9910_CR58","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/cas.13745","volume":"109","author":"M Liu","year":"2018","unstructured":"Liu, M., Zhang, H., Li, Y., Wang, R., Li, Y., Zhang, H., Ren, D., Liu, H., Kang, C., & Chen, J. (2018). HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer. Cancer science, 109, 2717\u20132733.","journal-title":"Cancer science"},{"key":"9910_CR59","doi-asserted-by":"crossref","unstructured":"G. Mor, M.K. Montagna, A.B. Alvero, Modulation of apoptosis to reverse chemoresistance, Methods in molecular biology (Clifton, N.J.), 414 (2008) 1-12.","DOI":"10.1007\/978-1-59745-339-4_1"},{"key":"9910_CR60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7827-1-66","volume":"1","author":"M Fraser","year":"2003","unstructured":"Fraser, M., Leung, B., Jahani-Asl, A., Yan, X., Thompson, W. E., & Tsang, B. K. (2003). Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reproductive biology and endocrinology : RB&E, 1, 66.","journal-title":"Reproductive biology and endocrinology : RB&E"},{"key":"9910_CR61","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman, J. S., & Lowe, S. W. (2003). Control of apoptosis by p53. Oncogene, 22, 9030\u20139040.","journal-title":"Oncogene"},{"key":"9910_CR62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong, R. S. (2011). Apoptosis in cancer: from pathogenesis to treatment. Journal of experimental & clinical cancer research : CR, 30, 87.","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"9910_CR63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.taap.2018.09.018","volume":"359","author":"J Han","year":"2018","unstructured":"Han, J., Han, B., Wu, X., Hao, J., Dong, X., Shen, Q., & Pang, H. (2018). Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway. Toxicology and applied pharmacology, 359, 55\u201361.","journal-title":"Toxicology and applied pharmacology"},{"key":"9910_CR64","doi-asserted-by":"crossref","first-page":"81452","DOI":"10.18632\/oncotarget.13263","volume":"7","author":"X Si","year":"2016","unstructured":"Si, X., Zang, R., Zhang, E., Liu, Y., Shi, X., Zhang, E., Shao, L., Li, A., Yang, N., Han, X., Pan, B., Zhang, Z., Sun, L., & Sun, Y. (2016). LncRNA H19 confers chemoresistance in ER\u03b1-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Oncotarget, 7, 81452\u201381462.","journal-title":"Oncotarget"},{"key":"9910_CR65","doi-asserted-by":"crossref","unstructured":"Wang, F., Zhou, J., Xie, X., Hu, J., Chen, L., Hu, Q., Guo, H., & Yu, C. (2015). Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells. Neoplasma.","DOI":"10.4149\/neo_2015_051"},{"key":"9910_CR66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.canlet.2016.08.015","volume":"382","author":"J Pan","year":"2016","unstructured":"Pan, J., Li, X., Wu, W., Xue, M., Hou, H., Zhai, W., & Chen, W. (2016). Long non-coding RNA UCA1 promotes cisplatin\/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer letters, 382, 64\u201376.","journal-title":"Cancer letters"},{"key":"9910_CR67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jcb.27327","volume":"120","author":"X Chen","year":"2019","unstructured":"Chen, X., Liu, M., Meng, F., Sun, B., Jin, X., & Jia, C. (2019). The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer. Journal of cellular biochemistry, 120, 243\u2013252.","journal-title":"Journal of cellular biochemistry"},{"key":"9910_CR68","first-page":"9325407","volume":"2019","author":"P Du","year":"2019","unstructured":"Du, P., Hu, C., Qin, Y., Zhao, J., Patel, R., Fu, Y., Zhu, M., Zhang, W., & Huang, G. (2019). LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer. Journal of oncology, 2019, 9325407.","journal-title":"Journal of oncology"},{"key":"9910_CR69","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/mt.2016.180","volume":"24","author":"B Yue","year":"2016","unstructured":"Yue, B., Cai, D., Liu, C., Fang, C., & Yan, D. (2016). Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer. Molecular therapy : the journal of the American Society of Gene Therapy, 24, 2064\u20132077.","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"9910_CR70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A., & Thiery, J. P. (2016). EMT: 2016. Cell, 166, 21\u201345.","journal-title":"Cell"},{"key":"9910_CR71","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41388-018-0378-x","volume":"37","author":"J van Staalduinen","year":"2018","unstructured":"van Staalduinen, J., Baker, D., Ten Dijke, P., & van Dam, H. (2018). Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? Oncogene, 37, 6195\u20136211.","journal-title":"Oncogene"},{"key":"9910_CR72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00280-016-3208-2","volume":"79","author":"HY Zhang","year":"2017","unstructured":"Zhang, H. Y., Liang, F., Zhang, J. W., Wang, F., Wang, L., & Kang, X. G. (2017). Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205. Cancer chemotherapy and pharmacology, 79, 327\u2013337.","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"9910_CR73","doi-asserted-by":"crossref","first-page":"10861","DOI":"10.1007\/s13277-016-4909-1","volume":"37","author":"YM Chen","year":"2016","unstructured":"Chen, Y. M., Liu, Y., Wei, H. Y., Lv, K. Z., & Fu, P. (2016). Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 10861\u201310870.","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"9910_CR74","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.2147\/OTT.S147586","volume":"10","author":"J An","year":"2017","unstructured":"An, J., Lv, W., & Zhang, Y. (2017). LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194. OncoTargets and therapy, 10, 5377\u20135390.","journal-title":"OncoTargets and therapy"},{"key":"9910_CR75","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/1535-7163.MCT-16-0591","volume":"16","author":"P Li","year":"2017","unstructured":"Li, P., Zhang, X., Wang, H., Wang, L., Liu, T., Du, L., Yang, Y., & Wang, C. (2017). MALAT1 Is Associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2. Molecular cancer therapeutics, 16, 739\u2013751.","journal-title":"Molecular cancer therapeutics"},{"key":"9910_CR76","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jcmm.13970","volume":"23","author":"J Jia","year":"2019","unstructured":"Jia, J., Zhan, D., Li, J., Li, Z., Li, H., & Qian, J. (2019). The contrary functions of lncRNA HOTAIR\/miR-17-5p\/PTEN axis and Shenqifuzheng injection on chemosensitivity of gastric cancer cells. Journal of cellular and molecular medicine, 23, 656\u2013669.","journal-title":"Journal of cellular and molecular medicine"},{"key":"9910_CR77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick, D., Barth, S., & Macleod, K. F. (2010). Autophagy: cellular and molecular mechanisms. The Journal of pathology, 221, 3\u201312.","journal-title":"The Journal of pathology"},{"key":"9910_CR78","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/08820139.2019.1682600","volume":"49","author":"BL Colhado Rodrigues","year":"2020","unstructured":"Colhado Rodrigues, B. L., Lallo, M. A., & Perez, E. C. (2020). The controversial role of autophagy in tumor development: a systematic review. Immunological investigations, 49, 386\u2013396.","journal-title":"Immunological investigations"},{"key":"9910_CR79","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B., & Guan, K. L. (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature cell biology, 13, 132\u2013141.","journal-title":"Nature cell biology"},{"key":"9910_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2019.12.001","volume":"63","author":"N Mizushima","year":"2019","unstructured":"Mizushima, N. (2019). The ATG conjugation systems in autophagy. Current opinion in cell biology, 63, 1\u201310.","journal-title":"Current opinion in cell biology"},{"key":"9910_CR81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2020.02.014","volume":"478","author":"W Zhang","year":"2020","unstructured":"Zhang, W., Liu, Y., Fu, Y., Han, W., Xu, H., Wen, L., Deng, Y., & Liu, K. (2020). Long non-coding RNA LINC00160 functions as a decoy of microRNA-132 to mediate autophagy and drug resistance in hepatocellular carcinoma via inhibition of PIK3R3. Cancer letters, 478, 22\u201333.","journal-title":"Cancer letters"},{"key":"9910_CR82","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12943-019-1016-0","volume":"18","author":"Q Cai","year":"2019","unstructured":"Cai, Q., Wang, S., Jin, L., Weng, M., Zhou, D., Wang, J., Tang, Z., & Quan, Z. (2019). Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Molecular cancer, 18, 82.","journal-title":"Molecular cancer"},{"key":"9910_CR83","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41419-018-1187-4","volume":"9","author":"M Wang","year":"2018","unstructured":"Wang, M., Han, D., Yuan, Z., Hu, H., Zhao, Z., Yang, R., Jin, Y., Zou, C., Chen, Y., Wang, G., Gao, X., & Wang, X. (2018). Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Cell death & disease, 9, 1149.","journal-title":"Cell death & disease"},{"key":"9910_CR84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-017-0743-3","volume":"16","author":"H YiRen","year":"2017","unstructured":"YiRen, H., YingCong, Y., Sunwu, Y., Keqin, L., Xiaochun, T., Senrui, C., Ende, C., XiZhou, L., & Yanfan, C. (2017). Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. Molecular cancer, 16, 174.","journal-title":"Molecular cancer"},{"key":"9910_CR85","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/onc.2016.521","volume":"36","author":"H Xiong","year":"2017","unstructured":"Xiong, H., Ni, Z., He, J., Jiang, S., Li, X., He, J., Gong, W., Zheng, L., Chen, S., Li, B., Zhang, N., Lyu, X., Huang, G., Chen, B., Zhang, Y., & He, F. (2017). LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene, 36, 3528\u20133540.","journal-title":"Oncogene"},{"key":"9910_CR86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-019-1017-z","volume":"18","author":"S Xu","year":"2019","unstructured":"Xu, S., Wang, P., Zhang, J., Wu, H., Sui, S., Zhang, J., Wang, Q., Qiao, K., Yang, W., Xu, H., & Pang, D. (2019). Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer. Molecular cancer, 18, 89.","journal-title":"Molecular cancer"},{"key":"9910_CR87","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.10.012","volume":"18","author":"E Quintana","year":"2010","unstructured":"Quintana, E., Shackleton, M., Foster, H. R., Fullen, D. R., Sabel, M. S., Johnson, T. M., & Morrison, S. J. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer cell, 18, 510\u2013523.","journal-title":"Cancer cell"},{"key":"9910_CR88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15283\/ijsc.2009.2.2.109","volume":"2","author":"Y Kim","year":"2009","unstructured":"Kim, Y., Joo, K. M., Jin, J., & Nam, D. H. (2009). Cancer stem cells and their mechanism of chemo-radiation resistance. International journal of stem cells, 2, 109\u2013114.","journal-title":"International journal of stem cells"},{"key":"9910_CR89","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ni.3517","volume":"17","author":"P Ntziachristos","year":"2016","unstructured":"Ntziachristos, P., Abdel-Wahab, O., & Aifantis, I. (2016). Emerging concepts of epigenetic dysregulation in hematological malignancies. Nature immunology, 17, 1016\u20131024.","journal-title":"Nature immunology"},{"key":"9910_CR90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12935-018-0538-7","volume":"18","author":"K Lohitesh","year":"2018","unstructured":"Lohitesh, K., Chowdhury, R., & Mukherjee, S. (2018). Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight. Cancer cell international, 18, 44.","journal-title":"Cancer cell international"},{"key":"9910_CR91","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/ijc.28922","volume":"135","author":"H Wang","year":"2014","unstructured":"Wang, H., Li, W., Guo, R., Sun, J., Cui, J., Wang, G., Hoffman, A. R., & Hu, J. F. (2014). An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies. International journal of cancer, 135, 2783\u20132794.","journal-title":"International journal of cancer"},{"key":"9910_CR92","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-18-1656","volume":"25","author":"X Chen","year":"2019","unstructured":"Chen, X., Xie, R., Gu, P., Huang, M., Han, J., Dong, W., Xie, W., Wang, B., He, W., Zhong, G., Chen, Z., Huang, J., & Lin, T. (2019). Long noncoding RNA LBCS inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2. Clinical cancer research : an official journal of the American Association for Cancer Research, 25, 1389\u20131403.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"9910_CR93","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1038\/s41388-019-0747-0","volume":"38","author":"W He","year":"2019","unstructured":"He, W., Liang, B., Wang, C., Li, S., Zhao, Y., Huang, Q., Liu, Z., Yao, Z., Wu, Q., Liao, W., Zhang, S., Liu, Y., Xiang, Y., Liu, J., & Shi, M. (2019). MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. Oncogene, 38, 4637\u20134654.","journal-title":"Oncogene"},{"key":"9910_CR94","doi-asserted-by":"crossref","first-page":"13616","DOI":"10.1038\/ncomms13616","volume":"7","author":"K Katsushima","year":"2016","unstructured":"Katsushima, K., Natsume, A., Ohka, F., Shinjo, K., Hatanaka, A., Ichimura, N., Sato, S., Takahashi, S., Kimura, H., Totoki, Y., Shibata, T., Naito, M., Kim, H. J., Miyata, K., Kataoka, K., & Kondo, Y. (2016). Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nature communications, 7, 13616.","journal-title":"Nature communications"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-020-09910-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T01:36:29Z","timestamp":1696296989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-020-09910-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9910"],"URL":"https:\/\/doi.org\/10.1007\/s10555-020-09910-w","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,27]]},"assertion":[{"value":"27 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}